By John EvansJul 3, 20201 minImmune checkpoints expressed in active, non-segmental vitiligoTwo immune checkpoints, Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and programmed death-1 (PD-1), appear to be present in the infl
By John EvansJun 26, 20202 minIsotretinoin use may reduce vitiligo riskData from an online survey of vitiligo patients suggests that, contrary to some case reports, the development of vitiligo may not be a poten
by Cory PerlaMar 18, 20201 minSkin cancer risk for patients with vitiligo does not increase after UVB phototherapyFor patients with vitiligo, extended treatment with narrowband ultraviolet B (UVB) phototherapy does not lead to an increase in skin cancer
By Dhiren MahibanJun 25, 20192 minRuxolitinib shows positive results for the treatment of vitiligoThe application of the medicated cream, ruxolitinib, showed improvement of facial vitiligo symptoms.